Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study.
about
Modern retinal laser therapyTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyPascal laser versus conventional laser for treatment of diabetic retinopathy.Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study.Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (SRT) in spectral domain OCT.Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.Diabetic macular edema: classification, medical and laser therapy."Light" versus "classic" laser treatment for clinically significant diabetic macular oedema.Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parametersInfluence of laser parameters on selective retinal treatment using single-phase heat transfer analyses.Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.Functional outcome of subthreshold versus threshold diode laser photocoagulation in diabetic macular oedema.Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen.The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema.Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.High-glucose-induced endothelial cell injury is inhibited by a Peptide derived from human apolipoprotein E.Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edemaNavigated focal laser photocoagulation for central serous chorioretinopathy.Side-effects and complications of laser treatment in diabetic retinal disease.Laser-based strategies to treat diabetic macular edema: history and new promising therapies.Localized thermal tumor destruction using dye-enhanced photothermal tumor therapy.Morphological and functional outcomes following modified early treatment diabetic retinopathy study laser in diabetic macular edemaSelective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.Morphologic changes in the retina after selective retina therapy.Significance of outer blood-retina barrier breakdown in diabetes and ischemia.Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.[Statement from the BVA, the DOG and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017].Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.Selective Retina Therapy with Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients.Selective retina therapy enhanced with optical coherence tomography for dosimetry control and monitoring: a proof of concept study.
P2860
Q26823096-95E4A8A0-E4F8-477E-B4E7-7EF68FEC3E8AQ28361141-DF590E2B-8530-4824-B953-1C4BB602504AQ30450684-23EDDBDD-699C-4703-A830-EC5C3D4F8724Q30848558-9A26E1FA-0CC8-4B8F-9B97-0620B9872CDCQ30877975-AE15DE04-62F8-4349-88B2-AB3C91857DC7Q31136758-7D4432A6-6D70-43A3-B6EF-28F373FCF605Q33208471-4FFB777F-2E1A-4AFC-854D-7A0907FB7751Q33217408-AE182101-6934-471A-918D-4CCCF75E6754Q33236165-20D07A06-9DB6-47A0-B864-0EA678ECA430Q33287030-36F67469-8E43-4D03-80FC-25B7CA11ADEEQ33521026-D4B93985-59CC-44AE-824F-C378068CF2AEQ33568530-A424032F-CB0A-48FF-91BC-9E176E55E9D1Q33771755-FB8FC40A-89EB-4331-8330-457142178E83Q34263219-D86FF1D9-389D-440E-A896-844BDC2A2D5DQ34269588-FEC185B1-BD77-4942-B38F-80576CC8C095Q34533160-97ED6AF5-4F9D-444D-9556-3573429A30C7Q35147159-7FF075AD-713C-49F4-B9F4-91DC7FC304B2Q35234670-DA15D319-BF99-4D0C-B4AC-3BB48B4566F6Q35344194-642307F1-6DE4-4765-8E61-CA095884FD44Q35353446-4FD7AFB6-2ACD-4046-921A-EB14CA703D21Q35656134-302BF7F8-7DDC-4A66-AC09-09FA42DB957CQ35856592-38ADF8BD-563E-44CB-A300-48230542B23BQ35906128-4D535A81-6ABE-4F89-8DE3-A3863E0F6688Q35991978-59216E48-1316-42C7-BBB0-2F1DC0179A2EQ41924777-BC246C09-4B61-46F7-842D-6078820A7DD8Q47816363-953634C5-5CE4-42C4-BFA6-1652719DE515Q49589259-B505B78D-4ABF-4A51-8B27-13D56BB34DC2Q50718210-67A27B2E-B5AE-4FE2-8532-2DE5BC4F6A26Q55400357-AF045136-0578-4CB5-8A5F-7BE95B90281CQ55437560-1531462D-86E4-420A-9713-EDFFFD799B61
P2860
Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@ast
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@en
type
label
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@ast
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@en
prefLabel
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@ast
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@en
P2093
P2860
P356
P1476
Subthreshold (retinal pigment ...... cular diseases: a pilot study.
@en
P2093
Birngruber R
Brinkmann R
Wirbelauer C
P2860
P356
10.1136/BJO.84.1.40
P407
P577
2000-01-01T00:00:00Z